openPR Logo
Press release

Cardiac Mapping System Market 2018-2028 | Analysis by Key Player; Biosense Webster, Johnson & Johnson, Boston Scientific, Abbott Laboratories, Aurora Health Care, Medtronic

07-24-2018 03:40 PM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

Cardiac diseases are the leading cause of death for both man and women. About 6,30,000 Americans die from the cardiac disease each year. The need of new diagnosis technologies is increasing with rising complex cardiac diseases prevalence. Most of the complex heart disease are needs complete diagnosis with safety and precisions. Cardiac mapping systems are the one of the diagnosis technique which identifies the temporal and spatial distribution of myocardial electrical potential. Cardiac mapping systems are most commonly used for effective diagnosis of the wide range of arrhythmias. More commonly cardiac mapping procedures are usually done through the catheter. Catheter inserts into the heart chamber percutaneously and recoding electro-grams sequentially. More commonly EP catheters are localized and navigated with the use of fluoroscopy. The 3-D cardiac mapping system is the new method of cardiac mapping with overcoming the limitation of conventional mapping. 3-D cardiac mapping systems offer the diagnosis of more complex arrhythmias such as macroreentrant AT, unstable VT, AF.

Request ToC of Report @ https://www.factmr.com/connectus/sample?flag=T&rep_id=1131

Cardiac Mapping System Market: Drivers and Restraints-

Adoption of cardiac mapping systems are increasing with time due to rising awareness regarding new technologies.  The elimination of errors in diagnosis helps the physician in providing better cure and treatment. Increase in the numbers of patients with arrhythmia and other cardiac disorders, increasing healthcare expenditure and rising inventions to reduce diagnosis errors. The cardiac mapping systems market is anticipated to grow with a significant CAGR owing to precision and patient safety enabled by real-time monitoring and diagnosis time reduction features. Increase in prevalence and diagnosis rate of cardiac disorder is the major factor which is creating the demand for cardiac mapping systems. Limited adoption of advanced cardiac mapping system and the high cost of services are expected to restrain global cardiac mapping system market.

Cardiac Mapping System Market: Segmentation

On the basis of technology, cardiac mapping system market can be segmented as:

• Cardiac radionuclide imaging
• Remote Navigation Systems
• Magnetic Navigation System
• Robotic Navigation Systems
On the basis of the end user, the cardiac mapping system market can be segmented as:
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Diagnosis Centers

Cardiac Mapping System Market: Overview

Cardiac mapping is basically used for measurement of electrical potential generated by chambers of heart. Evolution in technologies are occurring with time. New 3-D cardiac mapping systems are overcoming the features of conventional mapping systems with creation of three dimensional model of heart and track exact location of the catheter. New technologies in cardiac mapping systems allows movement of catheters without using X-ray. Advance cardiac mapping systems are designed to improve resolution, provide precision, gain quick cardiac activation maps. Now day’s real time positional management systems are widely used in cardiac mapping systems. Electro-anatomical mapping system are also widely used by professionals as it holds the potential to increase the efficacy and safety of catheters. These new technologies is very important because as the population ages, experiencing cardiac arrhythmias is expected to increase.

Cardiac Mapping System Market: Region-wise Outlook

In terms of geography, cardiac mapping system market has been divided into eight regions including North- America, Eastern Europe, Western Europe, and Asia- Pacific excluding China & Japan (APECJ), China, Japan, Middle-East & Africa and Latin America. North America is the most dominating market for cardiac mapping system market due to increasing healthcare expenditure and adoption of new technologies in cardiac mapping such as 3D mapping. Western Europe like Germany, France, and the UK is another fastest growing region in cardiac mapping system market due to growing healthcare practices and development of manufacturing facilities. APECJ region includes two fastest developing countries India and China, which provide the most promising market for cardiac mapping system market players. Due to factors like increasing awareness, rapid improvement in healthcare services, large population pool and increased prevalence of cardiac diseases.

To Know More About Report Click @ https://www.factmr.com/report/1131/cardiac-mapping-system-market

Cardiac Mapping System Market: Key Market Participants

Example of some key market participants in global cardiac mapping system market identify across the value chain are Biosense Webster Inc. (Johnson & Johnson), Boston Scientific Corporation, Medical Computer Systems Ltd., Abbott Laboratories, Aurora Health Care, Medtronic plc, General Electric Company and other.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain
Regional analysis includes:
• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia Pacific (India, ASEAN, Australia & New Zealand)
• China
• Japan
• Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current, and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare Market Research Reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us                                                        
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Mapping System Market 2018-2028 | Analysis by Key Player; Biosense Webster, Johnson & Johnson, Boston Scientific, Abbott Laboratories, Aurora Health Care, Medtronic here

News-ID: 1143543 • Views:

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance

All 5 Releases


More Releases for Cardiac

Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise. Request
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiac Monitoring & Cardiac Rhythm Management Devices
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest. Browse 145 Market Data Tables and 119 Figures spread
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,